Metastatic gastric carcinoma is a mortal disease with a median survival of barely 10 months. An approximate 20% of the cases overexpress HER2. and among them. the combination of chemotherapy with trastuzumab is actually the first-line palliative treatment. https://yeswellneses.shop/product-category/omegas/